Home > Research Areas > Cardiovascular Disease > Atherosclerosis
Cat. No. Product name CAS No.
DC7804 Anacetrapib(MK0859) Featured

Anacetrapib (MK0859) is a potent, selective, reversible rhCETP and mutant CETP(C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure. Phase 3.

875446-37-0
DC9861 BMS-779788(XL-652)

BMS-779788(XL652) is a novel small-molecule modulator of the Liver X Receptor (LXR), a nuclear hormone receptor implicated in a variety of cardiovascular and metabolic disorders.

918348-67-1
DC7397 Darapladib

Darapladib is a selective and orally active inhibitor of Lp-PLA2 (IC50= 270 pM)

356057-34-6
DC2072 LXR623 Featured

LXR-623 is a novel Liver X Receptor modulator

875787-07-8
DC9456 MK-0354

MK-0354 is a partial agonist of GPR109a receptor, for hGPR109a/ mGPR109a with EC50 of 1.65/1.08 μM, showed no activation of GPR109b.

851776-28-8
DC9609 Terutroban Featured

Terutroban is a thromboxane/prostaglandin endoperoxide receptor antagonist.

165538-40-9
DC7519 Torcetrapib Featured

Torcetrapib is a CETP inhibitor with IC50 of 37 nM, elevates HDL-C and reduces nonHDL-C in plasma. Phase 3.

262352-17-0
Page 1 / Total 1 FirstPrevNextLastGoto